Navigation Links
PDHI Launches ConXus Profile Third-Party Health Risk Assessment Data-Load Process
Date:6/23/2009

BERNARDSVILLE, N.J., June 23 /PRNewswire/ -- Protocol Driven Healthcare, Inc. (PDHI) launches the ConXus Profile Third-Party Health Risk Assessment (HRA) Data-Load Process so that organizations can merge historical data from third-party HRAs with data collected from the ConXus Profile HRA.

Organizations may be reluctant to switch their current HRA data to a new vendor for fear of losing valuable health information accumulated over time. PDHI has developed a solution in its ConXus Profile Third-Party HRA Data-Load Process. This new service enables organizations to take advantage of the data-management capability of the ConXus Platform while retaining historical HRA data.

Once third-party HRA data is loaded into the ConXus Platform, an organization can compare it with current data from ConXus Profile to provide:

  • Coach access to longitudinal HRA data for individual participants.
  • Administrator access to consolidated aggregate HRA data for outcome reporting.
  • Participant access to previous and current HRA results within the member report summary table for progress tracking.

One of the first companies to take advantage of this capability was Innovative Wellness Solutions, a client of PDHI. "Organizations are reluctant to change HRA vendors, as they do not want to lose their investment in the historical HRA data," said Stuart Sutley, chief executive officer of Innovative Wellness Solutions. "New clients can now adopt the ConXus Profile health risk assessment and take advantage of our other services that are supported on the integrated ConXus Platform. Centralizing all the program data makes it easy to track participation and measure program outcomes."

The PDHI ConXus Platform supports the delivery of private-labeled health improvement programs. Application modules include an HRA, online wellness programs, personal health record, and health-coaching tools. Application modules are delivered with the Program Center, which guides participants to required actions and key dates, a secure message center, and incentive tracking and fulfillment. Modules can be deployed in multiple configurations to match client service levels, with additional localization for each end client.

The ConXus Platform centralizes all program data, facilitating the tracking of program participation, return on investment, and changes in health status.

About Protocol Driven Healthcare, Inc.

PDHI is a healthcare technology and data processing organization that provides preventive health applications and services using the ConXus(R) health-improvement platform. For more information, visit http://www.pdhi.com/.

Recent News

PDHI --PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans

http://www.pdhi.com/webnew/corporate/pressreleases/Diabetes.asp

PDHI - PDHI's Health Risk Appraisal and Consumer Health Tools Awarded NCQA HIP Certification

http://www.pdhi.com/webnew/corporate/pressreleases/NCQA.asp

    Contact:
    David Abel
    Vice President of Sales and Marketing
    908-315-0365, ext. 1026
    davida@pdhi.com

'/>"/>
SOURCE Protocol Driven Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... , ... December 08, 2016 , ... David J. ... global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, ... the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... December 9, 2016 External ... Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators ... Cardioverter Defibrillators The global defibrillators ... CAGR of 5.3% from 2016-2020 and CAGR of ... grow at a CAGR of 5.2% from 2016 ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... the global optical transceiver market to grow at a CAGR of ... the present scenario and the growth prospects of the global optical ... considers the revenue generated from the shipment of optical transceivers worldwide ...
(Date:12/9/2016)... 9, 2016 Mitsubishi Tanabe Pharma Corporation (Head ... Director, CEO: Dr. Masayuki Mitsuka ) has presented ... given edaravone intravenously in 10-14 day cycles for 48 ... the ALS Functional Rating Scale-Revised (ALSFRS-R). The data were ... ALS/MND in Dublin, Ireland . ...
Breaking Medicine Technology: